Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

5.97
Delayed Data
As of Jul 29
 +0.01 / +0.17%
Today’s Change
3.33
Today|||52-Week Range
6.85
+43.17%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 7.50, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +25.63% increase from the last price of 5.97.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.00
Sales
$25.8M
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 

Sales

Growthquarterly 5.95%
 
 
 
 
 
 
Growthannually 16.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.